Skip to main content
Fig. 1 | Animal Diseases

Fig. 1

From: Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus

Fig. 1

Construction, expression and identification of EMCV-VLPs. Note: A. Construction diagram of AC-P12A-3C; B. Identification of Ac-P12A3C by western blot analysis. Lane 1 represents Sf9 cells infected with Ac-P12A-3C recombinant baculovirus; lane 2 represents Sf9 cells infected with Ac-WT; C. Identification of Sf9 cells infected with Ac-P12A-3C recombinant baculoviruses via IFA, bar: 50 μm. The primary antibody used was a monoclonal antibody, Anti-VP1, which was independently selected following the immunization of mice with VP1 expressed in a prokaryotic system

Back to article page

Animal Diseases

ISSN: 2731-0442